Version 1
: Received: 21 July 2022 / Approved: 22 July 2022 / Online: 22 July 2022 (03:12:31 CEST)
How to cite:
García Olivé, I.; Stojanovic, Z.; Martínez Rivera, C.; López Seguí, F.; Hernández Guillamet, G.; Vidal Alaball, J.; Abad Capa, J.; Rosell Gratacós, A. Impact of COVID-19 on Diagnosis of Respiratory Diseases in the Northern Metropolitan Area in Barcelona (Spain). Preprints2022, 2022070331. https://doi.org/10.20944/preprints202207.0331.v1
García Olivé, I.; Stojanovic, Z.; Martínez Rivera, C.; López Seguí, F.; Hernández Guillamet, G.; Vidal Alaball, J.; Abad Capa, J.; Rosell Gratacós, A. Impact of COVID-19 on Diagnosis of Respiratory Diseases in the Northern Metropolitan Area in Barcelona (Spain). Preprints 2022, 2022070331. https://doi.org/10.20944/preprints202207.0331.v1
García Olivé, I.; Stojanovic, Z.; Martínez Rivera, C.; López Seguí, F.; Hernández Guillamet, G.; Vidal Alaball, J.; Abad Capa, J.; Rosell Gratacós, A. Impact of COVID-19 on Diagnosis of Respiratory Diseases in the Northern Metropolitan Area in Barcelona (Spain). Preprints2022, 2022070331. https://doi.org/10.20944/preprints202207.0331.v1
APA Style
García Olivé, I., Stojanovic, Z., Martínez Rivera, C., López Seguí, F., Hernández Guillamet, G., Vidal Alaball, J., Abad Capa, J., & Rosell Gratacós, A. (2022). Impact of COVID-19 on Diagnosis of Respiratory Diseases in the Northern Metropolitan Area in Barcelona (Spain). Preprints. https://doi.org/10.20944/preprints202207.0331.v1
Chicago/Turabian Style
García Olivé, I., Jorge Abad Capa and Antoni Rosell Gratacós. 2022 "Impact of COVID-19 on Diagnosis of Respiratory Diseases in the Northern Metropolitan Area in Barcelona (Spain)" Preprints. https://doi.org/10.20944/preprints202207.0331.v1
Abstract
Objective: Several authors have analyzed the impact of the pandemic on the incidence rates of different conditions. Our aim was to analyze the impact of the COVID-19 pandemic on primary care new diagnoses of respiratory diseases. Methods: This was an observational retrospective study performed to describe the impact of COVID-19 pandemic on primary care new diagnosis of respiratory diseases other than lung cancer. Incidence rate ratio between pre-pandemic and pandemic period was calculated. Results: We found an decrease in the incidence of respiratory conditions (IRR 0.65) during the pandemic period. When we compared the different groups of diseases according to ICD-10, we found a significant decrease in the number of new cases during the pandemic period, except in the case of pulmonary tuberculosis, abscesses or necrosis of the lungs and other respiratory complications. Instead, we found increases in new diagnoses of flu and pneumonia (IRR 2.17) and respiratory interstitial diseases (IRR 1.41). Conclusion: There has been a decrease in new diagnosis of most respiratory diseases during the COVID-19 pandemic. The real clinical impact of this situation is still unknown. Large-scale real-life studies will make it possible to evaluate the long-term true impact of COVID-19 pandemic on the respiratory diseases management.
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
